ÂÜÀòÂÒÂ×

Philip Spear is an accomplished scientist with extensive experience in biotechnology and biomedical fields. Presently, Philip holds the position of Scientist at Solaris Vaccines and serves as an SBIR Commercialization Plan Writer at Grant Engine, where responsibilities include drafting commercialization plans and conducting market analyses. Additionally, Philip works as an Imaging Scientist at Biodock, focusing on AI-driven microscopy analysis. Previous roles include Scientist at Flagship Biosciences, where expertise in spatial biology and biomarker analysis was leveraged, and Quality Control Analyst at Novartis Gene Therapies, ensuring compliance within a cGMP environment. Philip's career also includes significant contributions as a Senior Scientist at Greffex, Inc., involving vaccine development and novel viral vector design. Philip earned a Bachelor of Science in Biology from Truman State University and a Doctorate in Biochemistry, Cell, and Molecular Biology from the University of California, Davis.